- Vaccines
- Drugs
- Feed Additives
North America Poultry Drugs Market report gives a comprehensive outlook across the globe with special emphasis on key countries such as United States and Canada. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, drug type, animal type and region. This report studies North America Poultry Drugs Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and service providers engaged.
North America Poultry Drugs Market Summary
Study Period
2023-29
Base Year
2022
CAGR
X%
Largest Market
United States
Fastest Growing Market
N/A
North America Poultry Drugs Market
Drugs are the chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. Rise in demand for health meat and eggs, increase in the R&D activities for the innovation of newer drugs, escalation in the prevalence of various infectious diseases, and high awareness about the poultry diseases and drugs in veterinary professionals are anticipated to boost the North America poultry drugs market. However, stringent regulatory policies for product approval, ban of antibiotics usage in poultry, high cost of R&D activities, and adverse effects associated with the drugs may restrain the growth of North America poultry drugs market over the forecast timeframe.
North America Poultry Drugs Market
United States dominates the market
Geographically, North America poultry drugs market is segmented into U.S. and Canada. U.S. poultry drugs market is growing due to increase in the R&D activities for the innovation of newer drugs, rise in prevalence infectious diseases, and increase in animal healthcare expenditure are boost the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis
North America Poultry Drugs Market Segmentation
Product Type
Drug Type
- Antibiotics
- Anti-gout Agents
- Anthelmintic
- Nutritional Supplements
- Anti-infectives
- Others
Animal Type
- Turkey
- Chicken
- Goose
- Duck
- Others
Country
- U.S.
- Canada
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
[urltag url='request-table-of-content']
- Zoetis (Pfizer, Inc.) (U.S.)
- Merck & Co. Inc. (U.S)
- Virbac S.A. (France)
- Boehringer Ingelheim Vetmedica (Germany)
- Elanco (U.S.)
- Bayer Animal Health (Germany)
- Phibro Animal health Corporation (U.S.)
- Zydus AHL (India)
- Ceva Sante Animale (France)